Literature DB >> 20112002

A118G polymorphism of OPRM1 gene is associated with schizophrenia.

Omar Serý1, Radovan Prikryl, Lukás Castulík, Frantisek St'astný.   

Abstract

Schizophrenia is ranked among multifactor diseases in whose pathogenesis, besides environmental factors, an interplay of functional polymorphisms of a larger number of candidate genes is involved. Neurodevelopmental abnormities are among the most accepted hypotheses in the etiology of schizophrenia. Recently, the role of oligodendrocytes in the development of the cortex has been cited repeatedly. During their various phases of differentiation oligodendrocytes present on their surfaces diverse receptors, among others the mu-opioid receptor (OPRM1). The study was focused on the relationship between the functional A118G polymorphism of the OPRM1 gene (rs1799971) and schizophrenia in groups of 130 male patients and 452 male controls. An association study revealed yet unpublished statistically significant difference of allelic and genotypic frequencies between the control and patient groups. According to our present knowledge, we assume that the OPRM1 gene polymorphism can influence the myelination of CNS neurons through regulations of expression of OPRM1 receptors on surfaces of oligodendrocytes. The neuronal myelination seems to be one of the important factors in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112002     DOI: 10.1007/s12031-010-9327-z

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  17 in total

1.  White matter abnormalities in early-onset schizophrenia: a voxel-based diffusion tensor imaging study.

Authors:  Sanjiv Kumra; Manzar Ashtari; Kelly L Cervellione; Inika Henderson; Hana Kester; David Roofeh; Jinghui Wu; Tana Clarke; Emily Thaden; John M Kane; Joseph Rhinewine; Todd Lencz; Alan Diamond; Babak A Ardekani; Philip R Szeszko
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-09       Impact factor: 8.829

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.

Authors:  I Micu; Q Jiang; E Coderre; A Ridsdale; L Zhang; J Woulfe; X Yin; B D Trapp; J E McRory; R Rehak; G W Zamponi; W Wang; P K Stys
Journal:  Nature       Date:  2005-12-21       Impact factor: 49.962

4.  White matter integrity of the whole brain is disrupted in first-episode schizophrenia.

Authors:  Yihui Hao; Zhening Liu; Tianzi Jiang; Gaolang Gong; Haihong Liu; Lihua Tan; Fan Kuang; Lin Xu; Yanhong Yi; Zishu Zhang
Journal:  Neuroreport       Date:  2006-01-23       Impact factor: 1.837

5.  Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study.

Authors:  D Peckys; G B Landwehrmeyer
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

6.  Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation.

Authors:  Claudia Rosin; Sergio Colombo; Andrew A Calver; Timothy E Bates; Stephen D Skaper
Journal:  Glia       Date:  2005-12       Impact factor: 7.452

7.  Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain.

Authors:  Emilse S Sanchez; John W Bigbee; Wambura Fobbs; Susan E Robinson; Carmen Sato-Bigbee
Journal:  Glia       Date:  2008-07       Impact factor: 7.452

Review 8.  A critique of the dopamine hypothesis of schizophrenia and psychosis.

Authors:  Joanna Moncrieff
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

9.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.

Authors:  Patrick R Hof; Vahram Haroutunian; Victor L Friedrich; William Byne; Cristian Buitron; Daniel P Perl; Kenneth L Davis
Journal:  Biol Psychiatry       Date:  2003-06-15       Impact factor: 13.382

10.  The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.

Authors:  Thomas Kroslak; K Steven Laforge; Robert J Gianotti; Ann Ho; David A Nielsen; Mary Jeanne Kreek
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

View more
  12 in total

Review 1.  Genetic factors modulating the response to stimulant drugs in humans.

Authors:  Amy B Hart; Harriet de Wit; Abraham A Palmer
Journal:  Curr Top Behav Neurosci       Date:  2012

2.  Association Study of OPRM1 Gene in a Sample of Schizophrenia Patients With Alcohol Dependence or Abuse.

Authors:  Marie N S Gendy; Clement Zai; Bernard Le Foll; James L Kennedy
Journal:  Can J Addict       Date:  2019-12

Review 3.  Opioid receptors: distinct roles in mood disorders.

Authors:  Pierre-Eric Lutz; Brigitte L Kieffer
Journal:  Trends Neurosci       Date:  2012-12-06       Impact factor: 13.837

4.  Association between 5q23.2-located polymorphism of CTXN3 gene (Cortexin 3) and schizophrenia in European-Caucasian males; implications for the aetiology of schizophrenia.

Authors:  Omar Šerý; Jan Lochman; Jana Povová; Vladimír Janout; Jiří Plesník; Vladimir J Balcar
Journal:  Behav Brain Funct       Date:  2015-03-17       Impact factor: 3.759

5.  No genetic association between A118G polymorphism of μ-opioid receptor gene and schizophrenia and bipolar disorders.

Authors:  Shaghayegh Yazdani; Vahid Salimi; Mohammad Reza Eshraghian; Mohammad Shayestehpour; Alireza Pourtalebi-Firoozabadi; Bizhan Romani; Azadeh Shadab; Mohammad Reza Aghasadeghi; Jila Yavarian
Journal:  Indian J Psychiatry       Date:  2017 Oct-Dec       Impact factor: 1.759

6.  Gene-Environment Interactions in Major Mental Disorders in the Czech Republic.

Authors:  Klara Latalova; Omar Sery; Kristyna Hosakova; Ladislav Hosak
Journal:  Neuropsychiatr Dis Treat       Date:  2020-05-06       Impact factor: 2.570

7.  Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes.

Authors:  Sarah E Morgan; Jakob Seidlitz; Kirstie J Whitaker; Rafael Romero-Garcia; Nicholas E Clifton; Cristina Scarpazza; Therese van Amelsvoort; Machteld Marcelis; Jim van Os; Gary Donohoe; David Mothersill; Aiden Corvin; Andrew Pocklington; Armin Raznahan; Philip McGuire; Petra E Vértes; Edward T Bullmore
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-19       Impact factor: 11.205

8.  Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.

Authors:  Saidan Ding; Bicheng Chen; Yong Zheng; Qin Lu; Leping Liu; Qǐ-Chuan Zhuge
Journal:  BMC Psychiatry       Date:  2013-04-05       Impact factor: 3.630

9.  Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain.

Authors:  Dario Kringel; Mari A Kaunisto; Catharina Lippmann; Eija Kalso; Jörn Lötsch
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

10.  Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging.

Authors:  Abhishekh H Ashok; Jim Myers; Tiago Reis Marques; Eugenii A Rabiner; Oliver D Howes
Journal:  Nat Commun       Date:  2019-10-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.